Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
Naunyn Schmiedebergs Arch Pharmacol ; 397(8): 5463-5481, 2024 08.
Article in English | MEDLINE | ID: mdl-38459989

ABSTRACT

This review paper provides an in-depth analysis of the significance of lipid nanocarriers in drug delivery and the crucial role of characterization techniques. It explores various types of lipid nanocarriers and their applications, emphasizing the importance of microscopy-based characterization methods such as light microscopy, confocal microscopy, transmission electron microscopy (TEM), scanning electron microscopy (SEM), and atomic force microscopy (AFM). The paper also delves into sample preparation, quantitative analysis, challenges, and future directions in the field. The review concludes by underlining the pivotal role of microscopy-based characterization in advancing lipid nanocarrier research and drug delivery technologies.


Subject(s)
Drug Carriers , Drug Delivery Systems , Lipids , Nanoparticles , Drug Carriers/chemistry , Lipids/chemistry , Humans , Animals , Microscopy/methods , Microscopy, Atomic Force
2.
Micron ; 179: 103595, 2024 04.
Article in English | MEDLINE | ID: mdl-38341939

ABSTRACT

The primary objective of this review is to present a comprehensive examination of the synthesis, characterization, and antibacterial applications of covalent organic frameworks (COFs). COFs represent a distinct category of porous materials characterized by a blend of advantageous features, including customizable pore dimensions, substantial surface area, and adaptable chemical properties. These attributes position COFs as promising contenders for various applications, notably in the realm of antibacterial activity. COFs exhibit considerable potential in the domain of antibacterial applications, owing to their amenability to functionalization with antibacterial agents. The scientific community is actively exploring COFs that have been imbued with metal ions, such as copper or silver, given their observed robust antibacterial properties. These investigations strongly suggest that COFs could be harnessed effectively as potent antibacterial agents across a diverse array of applications. Finally, COFs hold immense promise as a novel class of materials for antibacterial applications, shedding light on the synthesis, characterization, and functionalization of COFs tailored for specific purposes. The potential of COFs as effective antibacterial agents beckons further exploration and underscores their potential to revolutionize antibacterial strategies in various domains.


Subject(s)
Metal-Organic Frameworks , Metal-Organic Frameworks/pharmacology , Anti-Bacterial Agents/pharmacology , Silver/pharmacology , Copper/pharmacology , Porosity
3.
DNA Repair (Amst) ; 128: 103526, 2023 Aug.
Article in English | MEDLINE | ID: mdl-37406581

ABSTRACT

DNA methylation is one of the main epigenetic mechanisms in cancer development and progression. Aberrant DNA methylation of CpG islands within promoter regions contributes to the dysregulation of various tumor suppressors and oncogenes; this leads to the appearance of malignant features, including rapid proliferation, metastasis, stemness, and drug resistance. The discovery of two important protein families, DNA methyltransferases (DNMTs) and Ten-eleven translocation (TET) dioxygenases, respectively, which are responsible for deregulated transcription of genes that play pivotal roles in tumorigenesis, led to further understanding of DNA methylation-related pathways. But how these enzymes can target specific genes in different malignancies; recent studies have highlighted the considerable role of Long Non-coding RNAs (LncRNAs). LncRNAs recruit these enzymes to promoter regions of genes and mediate their functions, showing great potential as therapeutic agents targeting the epigenetic regulation of various genes. Considering the importance of combining the current treatment methods, especially chemotherapies, with DNA methylation inhibitors in improving patients' outcomes, this review aimed to summarize the recent findings about the interaction between DNA methylation machinery and LncRNAs in regulating genes involved in tumorigenesis and drug resistance. So, these studies could provide insights toward developing novel strategies for cancer-targeted therapy.


Subject(s)
Neoplasms , RNA, Long Noncoding , Humans , DNA Methylation , Epigenesis, Genetic , RNA, Long Noncoding/genetics , Neoplasms/drug therapy , Neoplasms/genetics , Carcinogenesis/genetics , Cell Transformation, Neoplastic/genetics , Drug Resistance
SELECTION OF CITATIONS
SEARCH DETAIL